Reshaping the Scientific Field With AI
AI is transforming scientific research by enabling real-time data processing and analysis on lab computers, with Dotmatics providing software that helps scientists capture and organize high-quality data to accelerate product, drug, and therapy development and personalize clinical treatments.
AI is reshaping human roles in the scientific field. Tasks that once required immense computing power and weeks to complete can now be run in real-time on a scientist's computer in the lab.
At Dotmatics, we empower scientists to capture top-quality data to be able to organize it for AI mechanisms, expediting the development of products, drugs, and therapies. By reducing the heavy lifting, our software allows scientists to identify effective compounds and enables clinicians to tailor treatments based on patient markers and phenotyping.
Watch the full video to learn more about the transformative potential of AI in scientific research and development.
Related
NBC Louisiana: How AI is Accelerating Drug Discovery
In an NBC Louisiana feature, Dotmatics’ VP Phil Mounteney explained how AI is revolutionizing drug discovery by significantly reducing development time from up to ten years to potentially half, enhancing efficiency in analyzing vast data sets while ensuring data privacy by keeping sensitive information secure and in-house.
Transforming Healthcare Through AI: Dotmatics Vision for a Healthier Future
Alister Campbell, VP at Dotmatics, highlighted in an NBC North Carolina feature how AI is revolutionizing healthcare by enabling more effective use of clinical data to accelerate medical discoveries and drug development—currently supporting 15 therapies in trials—while emphasizing the need for high-quality data and trustworthy AI models, with Dotmatics actively aiding over 2 million scientists worldwide to transform medicine for a healthier future.
USA Today: How Dotmatics is Powering the AI-Driven Future of Drug Discovery
The USA Today article highlights Dotmatics as a pivotal force in the AI-driven transformation of drug discovery, emphasizing its cloud-based data management platform and the launch of Luma, a multimodal drug discovery platform that enhances scientific innovation and R&D efficiency.
Addressing Inefficient R&D Workflows
The blog discusses how legacy, fragmented R&D systems hinder innovation in complex, multi-domain scientific research by creating silos and inefficiencies, and presents Dotmatics’ unifying platform as a comprehensive solution that integrates diverse tools, data, and teams to enable smarter collaboration, governed data use, and AI-driven automation for faster, more rigorous innovation.
Gray TV Washington DC: AI helping scientists make drug breakthroughs
The Gray TV Washington DC feature highlights how scientists, including Christian Olsen of Dotmatics, are leveraging AI and machine learning to accelerate drug discovery and expedite bringing new drugs to market.
Scripps News America Tonight
Phil Mounteney, VP of Science and Technology at Dotmatics, explains in Scripps News America Tonight how Dotmatics Luma uses AI to transform scientific research and pharmaceutical drug discovery by accelerating innovation, lowering costs, and shortening time-to-market for modern laboratories.